Prognostic significance of postoperative serological incomplete conversion of AFP and PIVKA-II after hepatic resection for hepatocellular carcinoma: a multicenter analysis of 1755 patients
The Oncologist · 06.12.2024 · 29 (12) · e1723-e1733
DOI: 10.1093/oncolo/oyae139 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Oncologist, online erschienen am 22.06.2024. Verfasst von Mingda Wang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Naval Medical University), Shanghai,…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Prothrombin, alpha-Fetoproteins. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Dawn Project Foundation of Shanghai, Shanghai Health and Hygiene Discipline Leader Project.
Abstract (Originalsprache)
Background
The value of serum biomarkers, particularly alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II), gains increasing attention in prognostic evaluation and recurrence monitoring for patients with hepatocellular carcinoma (HCC). This study investigated the implications of serological incomplete conversion (SIC) of these 2 biomarkers as prognostic indicators for long-term outcomes after HCC resection.
Methods
A multicenter observational study was conducted on a cohort of HCC patients presenting with AFP (>20 ng/mL) or PIVKA-II (>40 mAU/mL) positivity who underwent curative-intent resection. Based on their postoperative AFP and PIVKA-II levels at first postoperative follow-up (4~8 weeks after surgery), these patients were stratified into the serological incomplete conversion (SIC) and serological complete conversion (SCC) groups. The study endpoints were recurrence and overall survival (OS).
Results
Among 1755 patients, 379 and 1376 were categorized as having SIC and SCC, respectively. The SIC group exhibited 1- and 5-year OS rates of 67.5% and 26.3%, with the corresponding recurrence rates of 53.2% and 79.0%, respectively; while the SCC group displayed 1- and 5-year OS rates of 95.8% and 62.5%, with the corresponding recurrence rates of 16.8% and 48.8%, respectively (both P < .001). Multivariate Cox regression analysis demonstrated that postoperative SIC was an independent risk factor for both increased recurrence (HR: 2.40, 95% CI, 2.04-2.81, P < .001) and decreased OS (HR: 2.69, 95% CI, 2.24-3.24, P < .001).
Conclusion
The results emphasize that postoperative incomplete conversion of either AFP or PIVKA-II is a significant prognostic marker, indicating a higher risk for adverse oncologic outcomes following HCC resection. This revelation has crucial implications for refining postoperative adjuvant therapy and surveillance strategies for HCC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Naval Medical University), Shanghai, People's Republic of China.
- Department of Ultrasonic Intervention, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Naval Medical University), Shanghai, People's Republic of China.
- Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, First Hospital of Jilin University, Changchun, Jilin, People's Republic of China.
- Department of Hepatobiliary and Pancreatic Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, People's Republic of China.
- Department of Hepatobiliary Surgery, Affiliated Hospital of Nantong University, Nantong, People's Republic of China.
- Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital, Fujian Medical University, Fuzhou, People's Republic of China.
ORCID-Profile: Tian Yang
Förderung
- National Natural Science Foundation of China
- Dawn Project Foundation of Shanghai
- Shanghai Health and Hygiene Discipline Leader Project
- Shanghai Outstanding Academic Leader Program
- Natural Science Foundation of Shanghai
Zitieren
APA
Wang, M., Qian, G., Xiao, H., Liu, X., Sun, L., Chen, Z., Lin, K., Yao, L., Li, C., Gu, L., Xu, J., Sun, X., Qiu, W., Pawlik, T. M., Yee Lau, W., Lv, G., Shen, F., & Yang, T. (2024). Prognostic significance of postoperative serological incomplete conversion of AFP and PIVKA-II after hepatic resection for hepatocellular carcinoma: a multicenter analysis of 1755 patients. The Oncologist, 29(12), e1723-e1733. https://doi.org/10.1093/oncolo/oyae139
Vancouver
Wang M, Qian G, Xiao H, Liu X, Sun L, Chen Z, et al. Prognostic significance of postoperative serological incomplete conversion of AFP and PIVKA-II after hepatic resection for hepatocellular carcinoma: a multicenter analysis of 1755 patients. The Oncologist. 2024;29(12):e1723-e1733. doi:10.1093/oncolo/oyae139
BibTeX
@article{Wang2024,
author = {Wang, Mingda and Qian, Guojun and Xiao, Hongmei and Liu, Xingkai and Sun, Liyang and Chen, Zhong and Lin, Kongying and Yao, Lanqing and Li, Chao and Gu, Lihui and Xu, Jiahao and Sun, Xiaodong and Qiu, Wei and Pawlik, Timothy M and Yee Lau, Wan and Lv, Guoyue and Shen, Feng and Yang, Tian},
title = {Prognostic significance of postoperative serological incomplete conversion of AFP and PIVKA-II after hepatic resection for hepatocellular carcinoma: a multicenter analysis of 1755 patients},
journal = {The Oncologist},
year = {2024},
volume = {29},
number = {12},
pages = {e1723--e1733},
doi = {10.1093/oncolo/oyae139}
}
EUVIMED